Paris, le 19 décembre 2024. Le Conseil d’administration de Sanofi est heureux d’accueillir Jean-Paul Kress en qualité d’administrateur indépendant à compter du 1er janvier 2025, en remplacement de ...

La enfermedad pulmonar obstructiva crónica (EPOC) es la cuarta causa de muerte en todo el mundo, sin embargo, la forma en que tratamos a las personas que viven con esta enfermedad no ha cambiado ...

Deze Sanofi Privacyverklaring (“Beleid”) beschrijft de praktijken van SANOFI om te zorgen voor een adequate bescherming van persoonsgegevens, d.w.z. alle ...

EUROAPI is a leading player in active pharmaceutical ingredients (APIs) with a highly diverse portfolio of approximately 200 APIs for its “API Solutions” business and Contract Development and ...

Naimish Patel, Global Head of Development for Immunology and Inflammation & Erik Wallstroem, Head of Development, Neurology presenting at TD Cowen’s 44th Annual Health Care Conference. Fireside Chat : ...

Fireside chat with Giovanni Abbadessa, Head of Early Development Oncology ...

Thomas Grenier, Head of Franchise & Product Strategy, Sanofi Pasteur presenting at the J.P. Morgan European Healthcare Conference ...

Laurent Lhopitallier, Head of ESG Performances presenting at the Goldman Sachs Annual ESG Event ...

This is according to a report prepared for us at Sanofi by the analysis company Menon. Atopic dermatitis is a chronic inflammatory skin disease and people living with the more severe forms often ...

First quarter 2019 results were reviewed by management during a conference call with the financial community. The presentation was followed by a Q&A session. Our strong first quarter performance is a ...

Fireside chat with Dietmar Berger, Head of Development & CMO (11:10 a.m ET / 5:30 p.m CET) ...